Eleven Biotherapeutics, Inc. (EBIO) stock price ended its day with gain 5.79% and finalized at the value of $2.01. During its last trading session, Stock traded with the total exchanged volume of 3.69 million shares. The average volume stands around 0.44 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 8.46. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. Eleven Biotherapeutics, Inc. (EBIO) is a part of Healthcare sector and belongs to Biotechnology industry.
Important Technical Indicators:
ATR value of company was 0.12. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.
Relative Strength Index (RSI) was 52.36. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The stock volatility for week was 7.31% while for month was 6.06%.The stock, as of last close, traded 610.25% to its 52 week low and was changed -66.33% from its 52 week high. EBIO’s value Change from Open was at -1.95% with a Gap of 7.89%.
Earnings per share Details about EBIO:
EPS growth estimate for this year is set at 25.60%.
To review the EBIO previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost 7.49%.
During last one month it showed the change of -1.47%.
During last 3 month it remained at 0.50%.
During last one year month it performed at 450.68%.
Along with these its year to date performance is standing at 5.24%.
Analysts Mean Rating:
Analysts’ mean recommendation for Eleven Biotherapeutics, Inc. (EBIO) stands at 2.00. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
EBIO Stock Price Comparison to Moving Averages:
USA based company, Eleven Biotherapeutics, Inc. (EBIO)’s latest closing price was -24.01% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -2.20% and 3.02% compared with the 20 Day Moving Average.